We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » Managing FDA GCP/Bioresearch Monitoring Inspections - Webinar Recording/Transcript

Other Options

Audio Recording/Transcript - Oct. 31, 2017

$287.00

Audio Recording/Transcript - Oct. 31, 2017

$258.00

Audio Recording/Transcript - Oct. 31, 2017

$244.00

Audio Recording/Transcript - Oct. 31, 2017

$230.00

Audio Recording/Transcript - Oct. 31, 2017

$215.00

Managing FDA GCP/Bioresearch Monitoring Inspections - Webinar Recording/Transcript

$287.00
Webinar Recordings

Product Details

Managing FDA GCP/Bioresearch Monitoring Inspections

Clinical trial principal investigators and sponsors have their very own dedicated team of FDA inspectors, the Bioresearch Monitoring (BIMO) program staff. Washington public policy lawyer, David Rosen, has made a study of their inspection practices. He’s sharing his insights ... with you.

  • How principal investigator inspections are handled: authority and administration protocols, IRBs, consent forms, study records, financial disclosures, and electronic records and signatures.
  • How sponsor BIMO inspections are handled: registrations of studies, selection and monitoring of clinical investigators, selection of clinical research monitors, and quality assurance.

This fast-paced 90-minute presentation covers everything PIs and sponsors need to know about BIMO inspections:

  • How BIMO inspections are started and conducted
  • What the BIMO team is looking for in terms of following proper protocols for patient recruitment
  • FDA-recommended best practices in execution of consent forms, and whether patient volunteers are actually eligible participants in a clinical trial
  • How FDA determines whether you sufficiently identified PIs whose studies should have been or were terminated for non-compliance
  • How the FDA knows if sponsors have ensured that IRB approval is properly obtained prior to clinical trial enrollment
  • And much more!

Get inside the BIMO inspector’s head ... for hassle-free inspection visits, an end to writeups, and improved clinical practice in the bargain.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing